title: [The Stevens-Johnson syndrome from maprotiline and propranolol?].
abstract: A wide variety of agents have been associated with erythema multiforme, particularly drugs and infectious agents. We describe a typical Stevens-Johnson's syndrome developing 15 days after initiation of propranolol and maprotiline therapy. Other etiologies have been excluded by appropriate investigations and the responsibility of each drug is discussed.
authors.affiliation: Clinique dermatologique, vénéréologique et allergologique, Hôpital E. Herriot, Lyon.
authors.forename: P
authors.initials: P
authors.lastname: Zukervar
authors.forename: T
authors.initials: T
authors.lastname: Vial
authors.forename: P
authors.initials: P
authors.lastname: Jay
authors.forename: M
authors.initials: M
authors.lastname: Delcombel
authors.forename: J
authors.initials: J
authors.lastname: Descotes
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D008376:Maprotiline / Q000009:adverse effects*; D011433:Propranolol / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*
chemical_list: D008376:Maprotiline; D011433:Propranolol
vernacular_title: Syndrome de Stevens-Johnson sous maprotiline et propranolol?